-
Something wrong with this record ?
Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan
M. Douša, P. Gibala, S. Rádl, O. Klecán, Z. Mandelová, J. Břicháč, T. Pekárek
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Mass Spectrometry methods MeSH
- Drug Contamination MeSH
- Limit of Detection MeSH
- Magnetic Resonance Spectroscopy methods MeSH
- Oxazolidinones chemistry isolation & purification MeSH
- Oxazoles isolation & purification MeSH
- Spectrophotometry, Infrared methods MeSH
- Spectrophotometry, Ultraviolet methods MeSH
- Chemistry Techniques, Synthetic methods MeSH
- Tryptamines chemistry isolation & purification MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Publication type
- Journal Article MeSH
A new impurity was detected and determined using gradient ion-pair UHPLC method with UV detection in zolmitriptan (ZOL). Using MS, NMR and IR study the impurity was identified as (4S,4'S)-4,4'-(2,2'-(4-(dimethylamino)butane-1,1-diyl)bis(3-(2-(dimethylamino) ethyl)-1H-indole-5,2-diyl))bis(methylene)di(oxazolidin-2-one) (ZOL-dimer). The standard of ZOL-dimer was consequently prepared via organic synthesis followed by semipreparative HPLC purification. The UHPLC method was optimized in order to selectively detect and quantify other known and unknown process-related impurities and degradation products of ZOL as well. The presented method which was validated with respect to linearity, accuracy, precision and selectivity has an advantage of a very quick UHPLC chromatographic separation (less than 7 min including re-equilibration time) and therefore is highly suitable for routine analysis of related substances and stability studies of ZOL.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024339
- 003
- CZ-PrNML
- 005
- 20130331211640.0
- 007
- ta
- 008
- 120815s2012 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2011.08.043 $2 doi
- 035 __
- $a (PubMed)21982522
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Douša, Michal, $d 1968- $7 xx0060122 $u Zentiva, a.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic. hplc@hplc.cz
- 245 10
- $a Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan / $c M. Douša, P. Gibala, S. Rádl, O. Klecán, Z. Mandelová, J. Břicháč, T. Pekárek
- 520 9_
- $a A new impurity was detected and determined using gradient ion-pair UHPLC method with UV detection in zolmitriptan (ZOL). Using MS, NMR and IR study the impurity was identified as (4S,4'S)-4,4'-(2,2'-(4-(dimethylamino)butane-1,1-diyl)bis(3-(2-(dimethylamino) ethyl)-1H-indole-5,2-diyl))bis(methylene)di(oxazolidin-2-one) (ZOL-dimer). The standard of ZOL-dimer was consequently prepared via organic synthesis followed by semipreparative HPLC purification. The UHPLC method was optimized in order to selectively detect and quantify other known and unknown process-related impurities and degradation products of ZOL as well. The presented method which was validated with respect to linearity, accuracy, precision and selectivity has an advantage of a very quick UHPLC chromatographic separation (less than 7 min including re-equilibration time) and therefore is highly suitable for routine analysis of related substances and stability studies of ZOL.
- 650 _2
- $a techniky syntetické chemie $x metody $7 D060326
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a kontaminace léku $7 D004340
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a magnetická rezonanční spektroskopie $x metody $7 D009682
- 650 _2
- $a hmotnostní spektrometrie $x metody $7 D013058
- 650 _2
- $a oxazoly $x izolace a purifikace $7 D010080
- 650 _2
- $a oxazolidinony $x chemie $x izolace a purifikace $7 D023303
- 650 _2
- $a spektrofotometrie infračervená $x metody $7 D013055
- 650 _2
- $a spektrofotometrie ultrafialová $x metody $7 D013056
- 650 _2
- $a tryptaminy $x chemie $x izolace a purifikace $7 D014363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gibala, Petr
- 700 1_
- $a Rádl, Stanislav, $7 jx20061013029 $d 1951-
- 700 1_
- $a Klecán, Ondřej, $d 1973- $7 xx0125452
- 700 1#
- $a Mandelová, Zuzana. $7 _AN034059
- 700 1#
- $a Břicháč, Jiří. $7 xx0194030
- 700 1_
- $a Pekárek, Tomáš
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 58(2012), s. 1-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21982522 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20130331211924 $b ABA008
- 999 __
- $a ok $b bmc $g 946487 $s 781667
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 58 $d 1-6 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20120815/12/02